Download Free Sample Report

The global Non-sterile Liquid market was valued at US$ 2675.3 million in 2023 and is projected to reach US$ 3954.6 million by 2030, at a CAGR of 5.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Solution Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Non-sterile Liquid include Nycomed, AbbVie, Aenova, APPCO, Atral Pharmaceutical, Aurigene Pharmaceutical Services, Biological E. Ltd., BioPlus Life Sciences and Bora Pharmaceuticals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Non-sterile liquid can be used to deliver a variety of medications, including prescription drugs, non-prescription drugs, vitamins, dietary supplements, and nutraceuticals.
This report aims to provide a comprehensive presentation of the global market for Non-sterile Liquid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-sterile Liquid. This report contains market size and forecasts of Non-sterile Liquid in global, including the following market information:

• Global Non-sterile Liquid Market Revenue, 2019-2024, 2025-2030, ($ millions)

• Global Non-sterile Liquid Market Sales, 2019-2024, 2025-2030, (K Units)

• Global top five Non-sterile Liquid companies in 2023 (%)

We surveyed the Non-sterile Liquid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-sterile Liquid Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Non-sterile Liquid Market Segment Percentages, by Type, 2023 (%)

• Solution
• Suspension
• Gel
• Syrup
• Ethanolic Liquid

Global Non-sterile Liquid Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Non-sterile Liquid Market Segment Percentages, by Application, 2023 (%)

• Human Medication
• Nutraceuticals
• Cosmetics
• Medical Devices

Global Non-sterile Liquid Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Non-sterile Liquid Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Non-sterile Liquid revenues in global market, 2019-2024 (Estimated), ($ millions)
• Key companies Non-sterile Liquid revenues share in global market, 2023 (%)
• Key companies Non-sterile Liquid sales in global market, 2019-2024 (Estimated), (K Units)
• Key companies Non-sterile Liquid sales share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Nycomed
• AbbVie
• Aenova
• APPCO
• Atral Pharmaceutical
• Aurigene Pharmaceutical Services
• Biological E. Ltd.
• BioPlus Life Sciences
• Bora Pharmaceuticals
• Cambrex Corporation
• JGL d.d.
• Mikart
• PharmaVision
• Pierre Fabre
• TriRx Pharmaceutical Services
• UI Pharmaceuticals
• Wasdell Group

Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-sterile Liquid, market overview.
Chapter 2: Global Non-sterile Liquid market size in revenue and volume.
Chapter 3: Detailed analysis of Non-sterile Liquid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-sterile Liquid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non-sterile Liquid capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.